Abstract
Artemisinins are secondary metabolites of the medicinal plant Artemisia annua, have anti-inflammatory, anticarcinogenic, immunomodulating, antimicrobial and other properties. However, the pharmacokinetics, pharmacodynamics, exact molecular targets of artemisinin are not well known. The interaction of artemisinin with human serum albumin was studied both in vitro and in silico, and compared with dexamethasone. The quenching of the fluorescence emission of human serum albumin with artemisinin at different temperatures proceeded according to a single mechanism and indicated the static nature, which is similar to the effect of dexamethasone. Artemisinin and dexamethasone interact with Drug site I on human serum albumin. We have shown for the first time the formation of hydrogen bond with Arg218, which plays a crucial role in the binding of drugs at site I. Dexamethasone forms hydrogen bonds with the side chain of Arg218 and Arg222 and the main chain of Val343. The amino acids of subdomains IIA and IIIA of human serum albumin coincide for both compounds. Studies of the electrophoretic mobility of DNA of sarcoma S-180 cells show that artemisinin does not interact directly with DNA. Therefore, we assume that one of the main transporters of artemisinin is human serum albumin. Moreover, the interaction parameters of artemisinin with human serum albumin coincide with those of dexamethasone.
Similar content being viewed by others
REFERENCES
Krishna S., Bustamante L., Haynes R.K., Staines H.M. 2008. Artemisinins: Their growing importance in medicine. Trends Pharmacol. Sci.29, 520–527. https://doi.org/10.1016/j.tips.2008.07.004
Ali M., Abbasi B.H., Ahmad N., Khan H., Ali G.S. 2017. Strategies to enhance biologically active-secondary metabolites in cell cultures of Artemisia: Current trends. Crit. Rev. Biotechnol.37, 833–851. https://doi.org/10.1080/07388551.2016.1261082
Yao W., Wang F., Wang H. 2016. Immunomodulation of artemisinin and its derivatives. Sci. Bull.61, 1399–1406. https://doi.org/10.1007/s11434-016-1105-z
Lisgarten J.N., Potter B.S., Bantuzeko C., Palmer R.A. 1998. Structure, absolute configuration, and conformation of the antimalarial compound, Artemisinin. J. Chem. Crystallogr.28, 539–543. https://doi.org/10.1023/A:1023244122450
O’Neill P.M., Barton V.E., Ward S.A. 2010. The molecular mechanism of action of artemisinin: The debate continues. Molecules.15, 1705–1721. https://doi.org/10.3390/molecules15031705
Ho W.E., Peh H.Y., Chan T.K., Wong W.F. 2014. Artemisinins: Pharmacological actions beyond anti-malarial. Pharmacol. Ther.142, 126–139. https://doi.org/10.1016/j.pharmthera.2013.12.001
Kim W.S., Choi W.J., Lee S., Kim W.J., Lee D.C., Sohn U.D., Shin H.S., Kim W. 2014. Anti-inflammatory, antioxidant and antimicrobial effects of artemisinin extracts from Artemisia annua L. Korean J. Physiol. Pharmacol.19, 21. https://doi.org/10.4196/kjpp.2015.19.1.21
Bhaw-Luximon A., Jhurry D. 2017. Artemisinin and its derivatives in cancer therapy: Status of progress, mechanism of action, and future perspectives. Cancer Chemother. Pharmacol.79, 451–466. https://doi.org/10.1007/s00280-017-3251-7
Dai Y.F., Zhou W.W., Meng J., Du X.L., Sui Y.P., Dai L., Wang P.Q., Huo H.R., Sui F. 2017. The pharmacological activities and mechanisms of artemisinin and its derivatives: A systematic review. Med. Chem. Res.26, 867–880. https://doi.org/10.1007/s00044-016-1778-5
Tu Y. 2011. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat. Med.17, 1217–1220. https://doi.org/10.1038/nm.2471
Crespo-Ortiz M.P., Wei M.Q. 2012. Antitumor activity of artemisinin and its derivatives: From a well-known antimalarial agent to a potential anticancer drug. J. Biomed. Biotechnol.2012, 1–18. https://doi.org/10.1155/2012/247597
Das A.K. 2015. Anticancer effect of antimalarial artemisinin compounds. Ann. Med. Health Sci. Res.5, 93. https://doi.org/10.4103/2141-9248.153609
Shi Z., Chen Y., Lu C., Dong L.M., Lv J.W., Tuo Q.H., Qin L., Cheng S.W., Bu L.L., Lin N., Zhu X.X., Liao D.F., Liu X.M. 2018. Resolving neuroinflammation, the therapeutic potential of the anti-malaria drug family of artemisinin. Pharmacol. Res.136, 172–180. https://doi.org/10.1016/j.phrs.2018.09.002
Appalasamy S., Lo K.Y., Ch’ng S.J., Nornadia K., Othman A.S., Chan L.K. 2014. Antimicrobial activity of artemisinin and precursor derived from in vitro plantlets of Artemisia annua L. BioMed Res. Int.2014, 1–6. https://doi.org/10.1155/2014/215872
Li B., Yao Q., Pan X.C., Wang N., Zhang R., Li J., Ding G., Liu X., Wu C., Ran D., Zheng J., Zhou H. 2011. Artesunate enhances the antibacterial effect of β‑lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC. J. Antimicrob. Chemother.66, 769–777. https://doi.org/10.1093/jac/dkr017
Krungkrai J., Krungkrai S.R. 2016. Antimalarial qinghaosu/artemisinin: The therapy worthy of a Nobel prize. Asian Pac. J. Trop. Biomed.6, 371–375. https://doi.org/10.1016/j.apjtb.2016.03.010
Ginosyan S.V., Grabski H.V., Tiratsuyan S.G. 2017. Insights on glucocorticoid receptor modulation through binding of artemisinin. Biol. J. Armen.69, 104–109
Weikum E.R., Knuesel M.T., Ortlund E.A., Yamamoto K.R. 2017. Glucocorticoid receptor control of transcription: Precision and plasticity via allostery. Nat. Rev. Mol. Cell Biol.18, 159–174. https://doi.org/10.1038/nrm.2016.152
Bledsoe R.K., Montana V.G., Stanley T.B., Delves C.J., Apolito C.J., McKee D.D., Consler T.G., Parks D.J., Stewart E.L., Willson T.M., Lambert M.H., Moore J.T., Pearce K.H., Xu H.E. 2002. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell.110, 93–105. https://doi.org/10.1016/S0092-8674(02)00817-6
Ratman D., Mylka V., Bougarne N., Pawlak M., Caron S., Hennuyer N., Paumelle R., Cauwer L.D., Thommis J., Rider M.H., Libert C., Lievens S., Tavernier J., Staels B., Bosscher K.D. 2016. Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARα. Nucleic. Acids. Res.44, 10539–10553. https://doi.org/10.1093/nar/gkw742
Sundahl N., Bridelance J., Libert C., Bosscher K.D., Beck I.M. 2015. Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds. Pharmacol. Ther.152, 28–41. https://doi.org/10.1016/j.pharmthera.2015.05.001
Cruz-Topete D., Cidlowski J.A. 2015. One hormone, two actions: Anti- and pro-inflammatory effects of glucocorticoids. Neuroimmunomodulation.22, 20–32. https://doi.org/10.1159/000362724
Presman D.M., Hager G.L. 2017. More than meets the dimer: What is the quaternary structure of the glucocorticoid receptor? Transcription. 8, 32–39. https://doi.org/10.1080/21541264.2016.1249045
Conaway H.H., Henning P., Lie A., Tuckermann J., Lerner U.H. 2016. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity. Bone.93, 43–54. https://doi.org/10.1016/j.bone.2016.08.024
Yasseen Z.J., El-Ghossain M.O. 2016. Studies on binding of widely used drugs with human serum albumin at different temperatures and pHs. J. Biomed. Sci.5. https://doi.org/10.4172/2254-609X.100033
Chen R., Jiang H., Pu H. 2013. Interaction of artemisinin and its derivatives with human serum albumin studied using spectroscopies and molecular modeling methods. Mol. Biol. Rep.40, 4791–4804. https://doi.org/10.1007/s11033-013-2575-6
Marković O.S., Cvijetić I.N., Zlatović M.V., Opse-nica I.M., Konstantinović J.M., Jovanović N.V.T., Šolaja B.A., Verbić T.Ž. 2018. Human serum albumin binding of certain antimalarials. Spectrochim. Acta A: Mol. Biomol. Spectrosc.192, 128–139. https://doi.org/10.1016/j.saa.2017.10.061
Hananta L., Astuti I., Sadewa A.H., Alice J., Hutagalung J. 2018. The prevalence of CYP2B6 gene polymorphisms in malaria-endemic population of Timor in East Nusa Tenggara, Indonesia. Osong Public Health Res. Perspect.9, 192–196. https://doi.org/10.24171/j.phrp.2018.9.4.08
Maciążek-Jurczyk M., Szkudlarek A., Chudzik M., Pożycka J., Sułkowska A. 2018. Alteration of human serum albumin binding properties induced by modifications: A review. Spectrochim. Acta A: Mol. Biomol. Spectrosc.188, 675–683. https://doi.org/10.1016/j.saa.2017.05.023
Sudlow G., Birkett D.J., Wade D.N. 1976. Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol.12, 1052–1061
Lakowicz J.R. 2006. Principles of Fluorescence Spectroscopy. Boston, MA: Springer.
Lemkul J. 2019. From proteins to perturbed hamiltonians: A suite of tutorials for the GROMACS-2018 molecular simulation package [Article v1.0]. Living J. Comput. Mol. Sci.1. https://doi.org/10.33011/livecoms.1.1.5068
Pagadala N.S., Syed K., Tuszynski J. 2017. Software for molecular docking: A review. Biophys. Rev.9, 91–102. https://doi.org/10.1007/s12551-016-0247-1
Zhao H., Ge M., Zhang Z., Wang W., Wu G. 2006. Spectroscopic studies on the interaction between riboflavin and albumins. Spectrochim. Acta A: Mol. Biomol. Spectrosc.65, 811–817. https://doi.org/10.1016/j.saa.2005.12.038
Lissi E., Calderón C., Campos A. 2013. Evaluation of the number of binding sites in proteins from their intrinsic fluorescence: limitations and pitfalls. Photochem. Photobiol.89, 1413–1416. https://doi.org/10.1111/php.12112
Mahammed A., Gray H.B., Weaver J.J., Sorasaenee K., Gross Z. 2004. Amphiphilic corroles bind tightly to human serum albumin. Bioconjug. Chem.15, 738–746. https://doi.org/10.1021/bc034179p
Wang Y.Q., Su J., Wu F., Lu P., Yuan L.F., Yuan W.E., Sheng J., Jin T. 2012. Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery. Int. J. Nanomed.7, 693–704. https://doi.org/10.2147/IJN.S27849
Berman H.M. 2000. The protein data bank. Nucleic Acids Res.28, 235–242. https://doi.org/10.1093/nar/28.1.235
Petitpas I., Bhattacharya A.A., Twine S., East M., Curry S. 2001. Crystal structure analysis of warfarin binding to human serum albumin anatomy of drug site I. J. Biol. Chem.276, 22804–22809. https://doi.org/10.1074/jbc.M100575200
Webb B., Sali A. 2014. Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinformatics.47, 5.6.1–5.6.32. https://doi.org/10.1002/0471250953.bi0506s47
Lindorff-Larsen K., Piana S., Palmo K., Maragakis P., Klepeis J.L., Dror R.O., Shaw D.E. 2010. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins.78, 1950–1958. https://doi.org/10.1002/prot.22711
Jorgensen W.L., Chandrasekhar J., Madura J.D., Impey R.W., Klein M.L. 1983. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys.79, 926–935. https://doi.org/10.1063/1.445869
Daura X., Gademann K., Jaun B., Seebach D., Van Gunsteren W.F., Mark A.E. 1999. Peptide folding: When simulation meets experiment. Angew. Chem. Int. Ed.38, 236–240. https://doi.org/10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.0.CO;2-M
Offutt T.L., Swift R.V., Amaro R.E. 2016. Enhancing virtual screening performance of protein kinases with molecular dynamics simulations. J. Chem. Inf. Model.56, 1923–1935. https://doi.org/10.1021/acs.jcim.6b00261
Sadovnichy V., Tikhonravov A., Voevodin V., Opanasenko V. 2017. “Lomonosov”: Supercomputing at Moscow State University. In Contemporary High Performance Computing. New York: Chapman and Hall/CRC, pp. 283–307.
Bolton E.E., Wang Y., Thiessen P.A., Bryant S.H. 2008. PubChem: Integrated platform of small molecules and biological activities. In Annual Reports in Computational Chemistry. Elsevier, vol. 4, pp. 217–241.
Da Silva A.W.S., Vranken W.F. 2012. ACPYPE: Antechamber python parser interface. BMC Res. Notes. 5, 367. https://doi.org/10.1186/1756-0500-5-367
Wang J., Wolf R.M., Caldwell J.W., Kollman P.A., Case D.A. 2004. Development and testing of a general amber force field. J. Comput. Chem.25, 1157–1174. .https://doi.org/10.1002/jcc.20035
Trott O., Olson A.J. 2010. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem.31, 455–461. https://doi.org/10.1002/jcc.21334
Ruiz-Carmona S., Alvarez-Garcia D., Foloppe N., Garmendia-Doval A.B., Juhos S., Schmidtke P., Barril X., Hubbard R.E., Morley S.D. 2014. rDock: A fast, versatile and open source program for docking ligands to proteins and nucleic acids. PLoS Comput. Biol.10, e1003571. https://doi.org/10.1371/journal.pcbi.1003571
Wang Z., Sun H., Yao X., Li D., Xu L., Li Y., Tian S., Hou T. 2016. Comprehensive evaluation of ten docking programs on a diverse set of protein–ligand complexes: the prediction accuracy of sampling power and scoring power. Phys. Chem. Chem. Phys.18, 12964–12975. https://doi.org/10.1039/C6CP01555G
Gaudreault F., Najmanovich R.J. 2015. FlexAID: Revisiting docking on non-native-complex structures. J. Chem. Inf. Model.55, 1323–1336. https://doi.org/10.1021/acs.jcim.5b00078
Hotelling H. 1933. Analysis of a complex of statistical variables into principal components. J. Educ. Psychol.24, 417–441. https://doi.org/10.1037/h0071325
Rehman S.U., Asghar S., Fong S., Sarasvady S. 2014. DBSCAN: Past, present and future. IEEE. 232–238.
Grabski H., Tiratsuyan S. 2018. Mechanistic insights of the attenuation of quorum-sensing-dependent virulence factors of Pseudomonas aeruginosa: molecular modeling of the interaction of taxifolin with transcriptional regulator LasR. bioRxiv, 500157.
McKinney W. 2011. pandas: A foundational Python library for data analysis and statistics. Python High Perform. Sci. Comput.14.
Pedregosa F., Varoquaux G., Gramfort A., Michel V., Thirion B., Grisel O., Blondel M., Prettenhofer P., Weiss R., Dubourg V., Vanderplas J., Passos A., Cournapeau D., Brucher M., Perrot M., Duchesnay E. 2011. Scikit-learn: Machine learning in Python. J. Machine Learn. Res.12, 2825–2830.
O’Boyle N.M., Banck M., James C.A., Morley C., Vandermeersch T., Hutchison G.R. 2011. Open Babel: An open chemical toolbox. J. Cheminform.3. https://doi.org/10.1186/1758-2946-3-33
Wallace A.C., Laskowski R.A., Thornton J.M. 1995. LIGPLOT: A program to generate schematic diagrams of protein–ligand interactions. Protein Eng. Des. Sel.8, 127–134. https://doi.org/10.1093/protein/8.2.127
Peters T. 1996. All about Albumin: Biochemistry, Genetics, and Medical Applications. San Diego, CA: Academic Press.
Fanali G., Di Masi A., Trezza V., Marino M., Fasano M., Ascenzi P. 2012. Human serum albumin: From bench to bedside. Mol. Aspects Med.33, 209–290. https://doi.org/10.1016/j.mam.2011.12.002
Ma R., Guo D.X., Li H.F., Liu H.X., Zhang Y.R., Ji J.B., Xing J., Wang S.Q. 2019. Spectroscopic methodologies and molecular docking studies on the interaction of antimalarial drug piperaquine and its metabolites with human serum albumin. Spectrochim. Acta A: Mol. Biomol. Spectrosc.222, 117158. https://doi.org/10.1016/j.saa.2019.117158
Ross P.D., Subramanian S. 1981. Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry.20, 3096–3102. https://doi.org/10.1021/bi00514a017
Naik P.N., Chimatadar S.A., Nandibewoor S.T. 2010. Interaction between a potent corticosteroid drug— dexamethasone with bovine serum albumin and human serum albumin: A fluorescence quenching and fourier transformation infrared spectroscopy study. J. Photochem. Photobiol. B. Biol.100, 147–159. https://doi.org/10.1016/j.jphotobiol.2010.05.014
Förster T. 1948. Energy transfer and fluorescence between molecules. Ann Phys.437, 55–75.
Valeur B., Brochon J.C. 2001. New Trends in Fluorescence Spectroscopy: Applications to Chemical and Life Sciences. Berlin: Springer.
Foresman J.B., Frisch A. 1996. Exploring Chemistry with Electronic Structure Methods. Sec. Ed. Pittsburgh, PA: Gaussian, Inc.
Wang Y.Q., Su J., Wu F., Lu P., Yuan L.F., Yuan W.E., Sheng J., Jin T. 2012. Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery. Int. J. Nanomed.7, 693–704. https://doi.org/10.2147/IJN.S27849
Cai H.H., Yang P.H., Chen J., Liang Z.H., Chen Q., Cai J. 2009. Visual characterization and quantitative measurement of artemisinin-induced DNA breakage. Electrochim. Acta.54, 3651–3656. https://doi.org/10.1016/j.electacta.2009.01.042
Navaratnam V., Mansor S.M., Sit N.W., Grace J., Li Q., Olliaro P. 2000. Pharmacokinetics of artemisinin-type compounds. Clin. Pharmacokinet.39, 255–270. https://doi.org/10.2165/00003088-200039040-00002
Kimzey M.J., Yassine H.N., Riepel B.M., Tsaprailis G., Monks T.J., Lau S.S. 2011. New site (s. of methylglyoxal-modified human serum albumin, identified by multiple reaction monitoring, alter warfarin binding and prostaglandin metabolism. Chem. Biol. Interact.192, 122–128. https://doi.org/10.1016/j.cbi.2010.09.032
Mimoto M.S., Karaca A., Scherberg N., Dumitrescu A.M., Refetoff S. 2018. Homozygous mutation in human serum albumin and its implication on thyroid tests. Thyroid.28, 811–814. https://doi.org/10.1089/thy.2017.0564
Ha J.S., Ha C.E., Chao J.T., Petersen C.E., Theriault A., Bhagavan N.V. 2003. Human serum albumin and its structural variants mediate cholesterol efflux from cultured endothelial cells. Biochim. Biophys. Acta: Mol. Cell. Res.1640, 119–128. https://doi.org/10.1016/S0167-4889(03)00027-2
ACKNOWLEDGMENTS
Authors are thankful to the Laboratory of Toxinology and Molecular Systematics of L. A. Orbeli Institute of Phy-siology NAS RA.
The research is carried out using the equipment of the shared research facilities of HPC computing resources at Lomonosov Moscow State University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest.
This article does not contain any research involving humans or animals as subjects of research.
Additional information
Abbreviations: ART, artemisinin; hGR, human glucocorticoid receptor; DEXA, dexamethasone; HSA, human serum albumin; MD, molecular dynamics.
Supplementary material
Rights and permissions
About this article
Cite this article
Ginosyan, S., Grabski, H. & Tiratsuyan, S. In vitro and in silico Determination of the Interaction of Artemisinin with Human Serum Albumin. Mol Biol 54, 586–598 (2020). https://doi.org/10.1134/S0026893320040056
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893320040056